Gil Yosipovitch has been appointed to the scientific advisory board of Creabilis SA which is developing treatments for dermatological diseases. Professor Yosipovitch’s major clinical interest is pruritus and his research focuses on the neurophysiology of itch. He has a medical degree from the Sackler Faculty of Medicine at Tel Aviv University in Israel.
Also joining the advisory board is Praveen Anand, professor of clinical neurology and head of the Centre for Clinical Translation at Hammersmith Hospital, Imperial College, London, UK. Prof Anand is a clinical researcher in chronic pain.
Creabilis announced the appointments on 29 July 2013.
Copyright 2013 Evernow Publishing Ltd